Also categorized in Global Health:
FDA approves an Ebola vaccine, long in development, for the first time - Stat
x hide permanently

COVID-19 Severity Does Not Differ for Patients with Skin Conditions

Medical Xpress

Photo: Pixabay

MedicalXpress.com

For patients with psoriasis, vitiligo, atopic dermatitis (AD), and chronic urticaria (CU), COVID-19 severity does not differ, but treatment of COVID-19 may affect the course of skin disease, according to a letter to the editor published in the January 2022 issue of the Journal of the European Academy of Dermatology and Venereology.

Paulo Ricardo Criado, M.D., Ph.D., from the Centro Universitario Faculdade de Medicina do ABC in Brazil, and colleagues conducted a survey to examine acute COVID-19 symptoms, treatment, and changes in the clinical manifestation of psoriasis, vitiligo, AD, and CU in Brazil. Data ...